teins.11 5-181 The ability of IMS-MS to separate ions as they pass through an electric drift field allows components in protein mixtures to be separated and differentiated according to their size, charge, and conformation-dependent topography, as determined by differences in their collisional cross-sections.11 After applying IMS-MS to oligomerization-aggregation mixtures of aSyn in vitro, we report here the first identification of specific autoproteolytic truncation and degradation products that were previously observed by gel electrophoresis, but not identified. In particular, a highly aggregating fragment was identified by cleavage between Val71 and Thr72 in the centra l aggregation domain of aSyn,. Aggregation studies of the carboxy-terminal fragment, aSyn(72-140) prepared by both chemical synthesis and recombinant expression, showed a substantially faster fibrillization compared to the intact protein.
The in vitro oligomerization of aSyn was investigated by incubating it at 3r C in sodium phosphate buffer (pH 7.5) for up to 2S days according to a previously established procedure. 
; bands were revealed that corresponded to monomeric and oligomer-like aSyn with molecular weights of approximately 17, 35, and 48 kDa. In addition, protein bands with molecular weights lower than that of full-length aSyn were observed, with slowly increasing abundances over two weeks of incubation, thus indicating the formation of truncation and/or degradation products. The bands corresponding to aSyn monomer (1 a) at 17 kDa and dimer (1 a') at 35 kDa were excised from the gel, digested with trypsin, and ana lyzed by HPLC-ESI-MS (Table S2) . Sequencing of the tryptic peptides confirmed that the monomers and dimers of aSyn contain full-length sequences; indeed, we found all the expected tryptic peptides and no truncated sequences. Further structural characterization was obtained by N-terminal Edman sequencing after transfer of the proteins onto a polyvinylidene fluoride (PVDF) membrane, which yielded the first 20 amino acids of intact aSyn. Direct ESI-MS analysis of the aSyn incubation mixture after a short time period (3 h), however, revealed a small amount of N-terminally truncated aSyn lacking the first six amino acids (aSyn ; spot 1 b in Figures 1 and 52 , and Table Sl}. In contrast to these results, attempts to identify the degradation products (bands 1 C, 1 d, 1 e in Figure 1 ) by direct ESI-MS and HPLC-MS were unsuccessful, presumably owing to their low concentrations. After incubation of aSyn for four to 21 days, th e reaction mixtures were subjected to ion mobility-MS analysis, wh ich provides inherently three-dimensional data consisting of ion mobility-dependent drift t ime and separation according to differences in protein collisiona l cross sections,l1s, 16] mass/charge, and relative abundances, Broad-band admittance to the drift region afforded an ion-mobility plot of the incubation mixture after seven days and showed separation into two peaks corresponding to multiply charged ion series with different drift times (Figures 2 A and S3), These proteins were identified by molecular-mass determinations and ESI-tandem-MS sequencing ( Table S2 ) . In contrast, IMS-MS analysis of peak 1 at a decreased drift t ime revea led proteolytic products arising from N-and C-terminal truncation, a Syn(14-133) (12162.5 Da) and aSyn(40-140) (10436.4 Da); these correspond to the proteolytic gel bands 1 c and 1 e ( Figure 1 and Table Sl) , A remarkab le fragment was identified in the ion series within peak 1; it arose from cleavage between residues Val71 and Thr72 in the central amyloidogenic domain aSyn(61 -93) and corresponded to the gel electrophoresis band 1 d (Figure 1 ). This C -t ermina l fragment, aSyn(72-140) was identified by 1) accurate mass determination (7274.412 Da) and tandem-MS sequencing in the IMS-MS experiment (Figure 2 C, D) ; 2) incubation of aSyn for extended time periods (> 14 days), which afforded this fragment in amounts sufficient for direct elution of the electrophoretic band and identification by MALDI-MS (Table S1 ). Additional characterization of the C-termina l fragments aSyn(40-140) and aSyn(72-140) was obtained by affinity-mass spectrometryl21] and Western blot analysis w ith a monoclona l aSyn antibody that recognizes a C-termina l aSyn epitope, as identified by proteolytic-excision mass spectrometryl22] (data not shown),
The proteolytic fragment aSyn(72-140) was synthesized by 1) solid-phase peptide synthesis on a semiautomated peptide synthesizer by using the Fmoc strategy with double coupling and capping in the fina l 30 cycles (band 4), and 2) recombinant expression in E, co/i120] (band 5; Figure 1 ), Polypeptides prepared by both methods were purified to homogeneity by semipreparative HPLC; their molecular masses and sequences agreed with expected values as determined by ESI-MS and tandem-MS sequencing ( Figure S4 ) . Tris-tricine PAGE of 4 and 5 showed identical major bands corresponding to MWs of approximately 12 kDa; this is in agreement with the band of the autoproteolytic fragment 1 d of intact aSyn; remarkably, and in contrast to PAGE of intact aSyn, fragment 5 revea led the rapid formation of oligomers (Figure 3 A) . The in vitro aggregation of aSyn(72-140) 5 was ana lyzed in comparison with ful l-length aSyn 1 for up to five days at concentrations of 7-30/-lM by using thioflavin T (ThT) fluorescence l23 ] as an established fibri ll ization assay, and the results were compared with those of the oligomerization ana lysi s by using tris-tricine PAGE (Figure 3) , Although exact monitoring of fibrillization kinetics was hampered by the increasing insolubility of 5 at longer aggregation times, the results showed a substantially faster aggregation of aSyn(72-140), In contrast to full-length aSyn, the fragment 5 showed the typical sigmOidal curve characteristic of rea ctive aggregating polypeptides.
The autoproteolytic degradation of aSyn and the significance of the fragment aSyn(72-140) were ascertained from a number of additional mass spectrometric and gel electrophoresis data, and from control experiments with several synuclein polypeptides. Comparative in vitro studies of the nonaggregating brain protein, ~-synuclein (~Syn), which lacks the central amyloidogen ic domain (72-83), showed neither oligomerization -ag gregation nor any autoproteolytic cleavage within 21 days of incubation (Figure 1, lane 6) ; identical expression systems and HPLC purification procedures were employed for ~Syn and aSyn, thu s excluding aSyn degradation by an external protease, Further resu lts provided evidence to exclude a Dimer 28919 .6 proteolytic cleavage of aSyn by contaminating proteases: 1) Incubation of aSyn with and without addition of a broad spectrum of protease inhibitors yielded identical autoproteolytic degradation (Figure 1 right, lanes 1+ and 1) ; 2) Boiling samples prior to incubation and the use of sterile buffers did not lead to a change in aSyn autoproteolysis; and 3) Observation showed autoproteolytic degradation for aSyn mutants 2 and 3 in which the six residues (70-75) were exchanged against Ala and Gly (Figure 1 ). Moreover, a recent study on the interaction of aSyn with ~-glucocerebrosidase (GCa se), the target enzyme of Gaucher's disease, in cortical neurons lends additional support to the validity of our results, showing that the neurotoxicity-enhancing effect of aSyn upon depletion of GCase is abolished in a mutant aSyn that lacks the sequence 71 -82,1241
Further support for the importance of the central domain to the autoproteolysis of aSyn was obtained from initial hydrogen-deuterium exchange mass spectrometry (HDX-MS)12S1 stud-
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ies with high-resolution ESI-MS. HDX-MS of full-length aSyn 1 showed rapid exchange « 3 h) for 115 of the 134 backbone hydrogens, whereas 19 amino acids remained resistant to exchange for > 14 days (data not shown). Remarkably, an identical number of 19 amino acids in the aSyn(72-140) fragment 5 were found to be resistant to HDX (exact determination of the shielded domain is currently being performed). These results suggest shielding of a C-terminal part of th e hydrophobic amyloidogenic domain within residues 73/74 and 93, and are consistent with autoproteolytic accessibility at residues 71/72.
In conclusion, ion-mobility MS, owing to its capability to separate aSyn and its autoproteolytic products even though the concentration of the latter is small, enabled the characteri- tion products, might be amenable to examination by using specific functional aSyn residues. Thus, modification of ful llength aSyn 1 by amino-succinylation l261 provided a stable derivative succinylated at all Lys residues and at His50, as confirmed by ESI-MS; this succinylated aSyn did not show any aggregation or fragmentation, but did form a dimer ( Figure S5 ). The detailed biochemical evaluation of autoproteolytic products, presently being carried out in our laboratories, might provide a key to the elucidation of the oligomerization-agg regation mechanism of aSyn underlying its neurotoxicity. Moreover, the application of IMS-MS is expected to be highly valuable for identifying proteolytic products in the in vivo aggregation of aSyn.
Experimental Section
Gel electrophoresis of aSyn oligomerization in vitro: aSyn oligomers were prepared by incubation of several batches in triplicate using 5-30 iJ.M solutions for up to 25 days in sodium phosphate buffer (pH 7.5), as previously described. 1191 Proteins were solubilized and denatured by using stock so lutions of sample buffer (4% SOS, 25% glycerol, 50 mM Tris buffer, 6 M urea; pH 6.8). Gels were run at 100 V until the tracking dye reach ed the bottom. Separations were performed by tris-tricine PAGE on a MiniProtea n-3 cell (BioRad) with 12-15 % PAGE, and protein bands were vi sualized by Coomassie Blue and silver staining (90 x 60 x l mm gels).
For the protease inhibitor mixture (Complete-Mini; Roche Applied Science) about 50 iJ.M was disso lved in phosphate buffer (1.5 mL, 20 mM; pH 7.5).
Ion mobility mass spectrometry: Ion mobility mass spectrometry was performed on a Synapt-G 1 QTOF-mass spectrometer (Waters, Manchester, UK) equipped with an electrospray ionization source.
Ions were passed through a quadrupole, either set to transmit a substantial mass range or to select a particular mlz ion, before entering the Triwave ion mobility unit-a T-Wave trap unit for ion accumulation. Stored ions were gated (500 iJ.S) into the IMS T-Wave unit for separation according to their mobilities and passed to the T-Wave unit for transfer into the orthogonal-TOF analyzer l15al (Figure S3 A) . The pressures in the T-Wave trap and transfer region s were 7 x 10 2 mbar (argon) and 0.5 mbar (nitrogen), respectively; the sample injection volume was 5 iJ.l. Recombinant expression of full-length aSyn , and aSyn(72-140) 4 was performed by using the E. coli expression system BL 21 (DE3)
[pLys] strain and the T7 RNA polymerase system. Harvested cells were centrifuged (4000 g), resuspended in PBS, and heated for 2 min to 100°C; the cell suspension was centrifuged for 15 min at 4300g, and the protein wa s redissolved in PBS. HPLC purification of synthetic and recombinant aSyn polypeptides wa s performed with a BioRad-3000 semipreparative system on a Vydac-C4 column (250 x 4.6 mm) with a linea r gradient (0.1 % trifluoroacetic acid with 0 -> 80% acetonitrile) at a flow rate of 1 mLmin-1 ( Figure S4 ).
Thioflavin-T (ThT) aggregation: Purified aSyn , and aSyn(72-140) 5 (7-30 iJ.M) were disso lved in Na 2 HPO. (20 mM) containing 0.03% NaN 3 (pH 7.5) in microcentrifuge tubes, and triplicate solutions were incubated at 3rC w ith agitation. For ThT assays, a sample (23 iJ.l) was withdrawn at regular time intervals. The final assay volume (100 iJ.L) contained ThT (25 iJ.M) and protein (7 iJ.M); a blank of ThT (25 iJ.M) was used as a control. Determinations were performed in 96-well microtiter plates with a Victor-2 fluorescence plate reader (Perkin-Elmer) at A. x = 450 nm and Aem = 486 nm. Data were analyzed with Graph Pad Prism wherein the sigmoidal increase of the ThT fluorescence was ana lyzed.
